Literature DB >> 16596406

Outflow mechanisms after deep sclerectomy with two different designs of collagen implant in an animal model.

Christophe Nguyen1, Radu Christian Boldea, Sylvain Roy, Tarek Shaarawy, Sylvie Uffer, André Mermoud.   

Abstract

BACKGROUND: To study experimentally two different shapes of collagen implants (CI) used in deep sclerectomy (DS). The ability to promote drainage vessels, outflow mechanisms, success rates, and biodegradability, were studied prospectively in an animal model.
MATERIALS AND METHODS: DS was performed in 20 eyes of ten rabbits. Each rabbit randomly received a cylindrical CI in one eye, while the other eye received a flat CI. Intraocular pressure (IOP) measurement, ultrasound biomicroscopy (UBM) examination of DS site and simultaneous fluorescein and indocyanin green anterior-segment angiography were performed preoperatively, at 1 and 2 weeks, 1, 2, 3, 6 and 9 months for each eye. At the end of the follow-up period, outflow facility (OF) was measured and histological examinations of the filtration site were performed.
RESULTS: In the cylindrical implant group, IOP significantly dropped from a mean pre-operative value of 14.8+/-2.2 mmHg to a mean postoperative values of 10.9+/-3.3, 12.5+/-2.2, 11.8+/-2.6, 11.2+/-2.3, 10.7+/-1.9, 14.0+/- 3.2, 12.6+/-2.4 mmHg at 1, 2 weeks, and 1, 2, 3, 6, and 9 months, respectively. In the flat CI group, IOP significantly dropped from a mean preoperative value of 14.1+/-1.8 mmHg to a mean postoperative values of 10.4+/-2.7, 12.7+/-1.9, 12.5+/-3.2, 11.2+/-1.6, 11.6+/-1.8, 11.5+/-2.3, 11.0+/-2.2 mmHg at 1, 2 weeks, and at 1, 2, 3, 6, and 9 months, respectively. UBM images showed a gradual resorption of both type of CI during the first 3 months, and angiographies showed progressive growth of drainage vessels around the filtration site in both groups. The mean OF 9 months postoperatively for the cylindrical CI was 0.53 (SD +/- 0.23) ml/ min per mmHg and was 0.56 (SD+/-0.17) ml/min per mmHg for the flat CI (P=0.6). Histological examination revealed excellent biocompatibilty and a high density of drainage vessels in the sclera around the operative site in both groups.
CONCLUSION: Using IOP and OF measurements, UBM, angiography, and histology, we were able to compare two types of CI used as space maintainer in DS. Both CIs showed efficient IOP lowering effect and outflow facility increase, possibly explained by stimulation of drainage vessels growth. Both implants showed excellent biocompatibility. The flat CI showed a slight tendency towards better overall performances.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596406     DOI: 10.1007/s00417-006-0275-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  [Non-perforating surgery of the trabeculum with reticulated hyaluronic acid implant: why, how, what results?].

Authors:  P Sourdille; P Y Santiago; Y Ducournau
Journal:  J Fr Ophtalmol       Date:  1999 Aug-Sep       Impact factor: 0.818

2.  Viscocanalostomy for open-angle glaucoma in black African patients.

Authors:  R Stegmann; A Pienaar; D Miller
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

3.  Deep sclerectomy with collagen implant: medium term results.

Authors:  M E Karlen; E Sanchez; C C Schnyder; M Sickenberg; A Mermoud
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

4.  Ultrasound biomicroscopy of eyes undergoing deep sclerectomy with collagen implant.

Authors:  A G Chiou; A Mermoud; S E Hédiguer; C C Schnyder; R Faggioni
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

5.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

6.  The complications of trabeculectomy (a 20-year follow-up).

Authors:  P G Watson; C Jakeman; M Ozturk; M F Barnett; F Barnett; K T Khaw
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  Otago glaucoma surgery outcome study: long-term results of trabeculectomy--1976 to 1995.

Authors:  A C Molteno; N J Bosma; J M Kittelson
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

8.  [Aqueous outflow pathway imaging in the rabbit with fluorescein and indocyanine green].

Authors:  S Roy; R Boldea; D Perez; M Curchod; A Mermoud
Journal:  Klin Monbl Augenheilkd       Date:  2000-05       Impact factor: 0.700

9.  Five-year results of deep sclerectomy with collagen implant.

Authors:  T Shaarawy; M Karlen; C Schnyder; F Achache; E Sanchez; A Mermoud
Journal:  J Cataract Refract Surg       Date:  2001-11       Impact factor: 3.351

View more
  6 in total

1.  Biocompatibility of an x-shaped zirconium implant in deep sclerectomy in rabbits.

Authors:  Alessia Basso; Sylvain Roy; André Mermoud
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-28       Impact factor: 3.117

2.  [Deep sclerectomy. An alternative to trabeculectomy].

Authors:  M Klemm
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

3.  Viscocanalostomy combined with trabeculotomy and mitomycin C in the treatment of primary congenital glaucoma.

Authors:  Chao-Xu Qian; Yuan Zong; Qin Chen; Zhi-Lan Yuan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

4.  In vivo biocompatibility assessment of (PTFE-PVDF-PP) terpolymer-based membrane with potential application for glaucoma treatment.

Authors:  Rafał Leszczynski; Ewa Stodolak; Jarosław Wieczorek; Jolanta Orlowska-Heitzman; Teresa Gumula; Stanislaw Blazewicz
Journal:  J Mater Sci Mater Med       Date:  2010-07-23       Impact factor: 3.896

5.  Intrascleral outflow after deep sclerectomy with absorbable and non-absorbable implants in the rabbit eye.

Authors:  Jakub J Kałużny; Dariusz Grzanka; Halina Wiśniewska; Alicja Niewińska; Bartłomiej J Kałużny; Alina Grzanka
Journal:  Med Sci Monit       Date:  2012-10

6.  A new manner of reporting pressure results after glaucoma surgery.

Authors:  Constantin-Dan Bordeianu; Cristina-Eugenia Ticu
Journal:  Clin Ophthalmol       Date:  2011-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.